ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · Real-Time Price · USD
1.545
-0.045 (-2.83%)
Mar 20, 2026, 12:38 PM EDT - Market open
ProQR Therapeutics Revenue
In the year 2025, ProQR Therapeutics had annual revenue of 15.91M EUR, down -15.86%. ProQR Therapeutics had revenue of 4.69M in the quarter ending December 31, 2025, with 8.85% growth.
Revenue (ttm)
15.91M EUR
Revenue Growth
-15.86%
P/S Ratio
8.56
Revenue / Employee
95,762 EUR
Employees
166
Market Cap
162.78M USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 15.91M | -3.00M | -15.86% |
| Dec 31, 2024 | 18.91M | 12.39M | 190.22% |
| Dec 31, 2023 | 6.51M | 2.92M | 81.25% |
| Dec 31, 2022 | 3.59M | 2.26M | 169.21% |
| Dec 31, 2021 | 1.34M | -8.12M | -85.88% |
| Dec 31, 2020 | 9.45M | 7.52M | 388.98% |
| Dec 31, 2019 | 1.93M | -3.83M | -66.45% |
| Dec 31, 2018 | 5.76M | 4.27M | 285.35% |
| Dec 31, 2017 | 1.50M | -333.00K | -18.22% |
| Dec 31, 2016 | 1.83M | -1.41M | -43.49% |
| Dec 31, 2015 | 3.24M | 2.92M | 933.55% |
| Dec 31, 2014 | 313.00K | 197.00K | 169.83% |
| Dec 31, 2013 | 116.00K | 93.00K | 404.35% |
| Dec 31, 2012 | 23.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Precision BioSciences | 34.26M |
| Evaxion | 7.53M |
| Whitehawk Therapeutics | 7.15M |
| Cartesian Therapeutics | 2.80M |
| Molecular Partners AG | 856.30K |
| Connect Biopharma Holdings | 762.00K |
| Adagene | 103.20K |
PRQR News
- 1 day ago - ProQR Therapeutics N.V. (PRQR) Presents at The Citizens Life Sciences Conference 2026 Transcript - Seeking Alpha
- 8 days ago - ProQR Announces Year End 2025 Operating and Financial Results - GlobeNewsWire
- 16 days ago - ProQR Announces Webcast of Presentation at the 2026 Citizens Life Sciences Conference - GlobeNewsWire
- 5 weeks ago - ProQR Announces Planned Changes to Board Composition - GlobeNewsWire
- 2 months ago - ProQR Announces Encouraging AX-0810 Phase 1 Safety and PK Data, Development Candidate Selections, and 2026 Outlook - GlobeNewsWire
- 3 months ago - ProQR to Participate in 8th Annual Evercore Healthcare Conference - GlobeNewsWire
- 4 months ago - ProQR Announces Third Quarter 2025 Operating and Financial Results - GlobeNewsWire
- 4 months ago - ProQR Therapeutics N.V. (PRQR) Shareholder/Analyst Call Transcript - Seeking Alpha